Atazanavir Sulphate
₹150.00
Applications
Atazanavir (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV).
Description
Atazanavir Sulfate is a sulfate salt form of atazanavir, an aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors.
Preparation
According to an aspect of the present invention, there is provided a process for the preparation of Compound (A) that comprises preparing atazanavir sulphate by treating atazanavir base (Compound (II)) with sulphuric acid in a combination of solvents, and isolating Compound (A).
Chemical Properties
Atazanavir sulfate is a white to pale yellow crystalline powder with low solubility in water, known for its antiviral properties, and is a vital component in the treatment of HIV infection.
Definition
Atazanavir sulfate is a sulfated derivative of atazanavir, a protease inhibitor used in the treatment of HIV/AIDS by inhibiting the HIV protease enzyme.
Description
Product Name | Atazanavir Sulphate |
Brand | indian |
Country of Origin | Made in India |
Usage | Pharma |
Formula | C38H54N6O11S |
Molar Mass | 704.856 g/mol |
CAS ID | 198904-31-3 |
Elimination half-life | 6.5 hrs |
Bioavailability | 68% |
Molecular Weight | 802.94 |
Melting point | 195.0°, or acetone; mp 198-199° (dec) |
alpha | D22 -46.1° (c = 1 in 1:1 CH3OH/H2O, pH = 2.6) |
storage temp | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | ≥28.7 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥4.05 mg/mL in EtOH with gentle warming and ultrasonic |
form | Powder |
Packaging Size | As Per Requirement |
Our Export Location as a Atazanavir Sulphate Manufacturer, Supplier, Exporter, Stockist from India.
Afghanistan
Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Austrian Empire Azerbaijan Baden Bahamas Bahrain Bangladesh Barbados Bavaria Belarus Belgium Belize Benin (Dahomey) Bolivia Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mecklenburg-Schwerin Mecklenburg-Strelitz Mexico Micronesia Moldova Monaco Mongolia Montenegro |
Bosnia and Herzegovina
Botswana Brazil Brunei Brunswick and Lüneburg Bulgaria Burkina Faso Burma Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Central American Federation Chad Chile China Colombia Comoros Congo Free State Costa Rica Morocco Mozambique Namibia Nassau Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria North German Confederation North German Union North Macedonia Norway Oldenburg Oman Orange Free State Pakistan Palau Panama Papal States |
Cote d’Ivoire Croatia Cuba Cyprus Czechia Czechoslovakia Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Duchy of Parma East Germany Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Federal Government of Germany Fiji Papua New Guinea Paraguay Peru Philippines Piedmont-Sardinia Poland Portugal Qatar Republic of Genoa* Republic of Korea (South Korea) Republic of the Congo Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia |
Schaumburg-Lippe* Finland France Gabon Gambia Georgia Germany Ghana Grand Duchy of Tuscany Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Hanover Hanseatic Republics Hawaii Hesse Holy See Honduras Hungary Iceland Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syria Tajikistan Tanzania Texas Thailand |
India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kingdom of Serbia/Yugoslavia Kiribati Korea Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Lew Chew (Loochoo) Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Two Sicilies* Uganda Ukraine Union of Soviet Socialist Republics* United Arab Emirates United Kingdom Uruguay Uzbekistan Vanuatu Venezuela Vietnam Württemberg* Yemen Zambia Zimbabwe |
Reviews
There are no reviews yet.